Source facts
FDA posted an approval letter for DAPAGLIFLOZIN on 2026-06-09. This is the document posting date; consult the signed letter for the decision date. The source metadata identifies ANDA 211156 as an original application. Review the exact FDA letter for the approved conditions and labeling.
